During regular trading hours, there were many stocks that continued to break up to the upside. These stocks are usually going up with news.If you are looking to day trade also check out my Top 2011 Stock Gainers, Stocks to Buy 2012.You can also check previous stocks to buy reports- Right Here today.Hot stocks Today Right Here.I also have technical analysis different stocks-Right Here. Market Technical analysis Right Here
Quick Look Market Closing Price:
At the close: Dow +0.09% to 13336. S&P +0.31% to 1438. Nasdaq +0.31% to 3114.
Treasurys: 30-year -0.73%. 10-yr -0.3%. 5-yr -0.11%.
Commodities: Crude -0.3% to $96.88. Gold -0.02% to $1731.95.
Currencies: Euro +0.28% vs. dollar. Yen +0.12%. Pound -0.2%.
Treasurys: 30-year -0.73%. 10-yr -0.3%. 5-yr -0.11%.
Commodities: Crude -0.3% to $96.88. Gold -0.02% to $1731.95.
Currencies: Euro +0.28% vs. dollar. Yen +0.12%. Pound -0.2%.
After Hours News:
K12 (LRN): FQ4 EPS of $0.05 beats by $0.08. Revenue of $170.4M (+32.8% Y/Y) beats by $5M. Shares +2.9% AH
HFF (HF) will replace Stratasys (SSYS) in the S&P SmallCap 600 index after the close of trading on Tuesday, September 18. Stratasys is merging with privately held Objet in a deal expected to be completed soon. HF+4.5%, SSYS -3.8% AH.
Pall (PLL): FQ4 EPS of $0.73 misses by $0.04. Revenue of $783.7M (+0.4% Y/Y) beats by $65M. Shares +4.8% AH.
Sanofi (SNY) wins U.S. FDA approval for Aubagio, a pill designed to treat multiple sclerosis, making it the second oral therapy that will be available on the U.S. market. The drug will compete with Novartis' (NVS) Gilenya, an oral pill which was approved by the FDA in 2010
K12 (LRN): FQ4 EPS of $0.05 beats by $0.08. Revenue of $170.4M (+32.8% Y/Y) beats by $5M. Shares +2.9% AH
HFF (HF) will replace Stratasys (SSYS) in the S&P SmallCap 600 index after the close of trading on Tuesday, September 18. Stratasys is merging with privately held Objet in a deal expected to be completed soon. HF+4.5%, SSYS -3.8% AH.
Pall (PLL): FQ4 EPS of $0.73 misses by $0.04. Revenue of $783.7M (+0.4% Y/Y) beats by $65M. Shares +4.8% AH.
Sanofi (SNY) wins U.S. FDA approval for Aubagio, a pill designed to treat multiple sclerosis, making it the second oral therapy that will be available on the U.S. market. The drug will compete with Novartis' (NVS) Gilenya, an oral pill which was approved by the FDA in 2010
DSW (DSW) declared special dividend of $2.00/share. For shareholders of record Oct 16. Payable Oct 26. Ex-div date Oct 12. The company had earlier declared regular quarterly dividend of $0.18/share, in line with previous. Forward yield 1.12%. For shareholders of record Sep 18. Payable Sep 28. Ex-div date Sep 14. Shares +1.9% AH.
Chicago Bridge & Iron (CBI) declares $0.05/share quarterly dividend, in line with previous. Forward yield 0.50%. For shareholders of record Sep 21. Payable Sep 28. Ex-div date Sep 19. Shares +0.3% AH
Two Harbors Investment (TWO) declares $0.36/share quarterly dividend, 10% decrease from prior dividend of $0.40. Forward yield 12.1%. For shareholders of record Sep 24. Payable Oct 22. Ex-div date Sep 20. Shares -1.7% AH
http://daytradingstock-blog.blogspot.com
